Abstract:It is generally accepted that viral and cellular products from immune competent mononuclear phagocytes (MP) (brain macrophages and microglia) underlie the neuropathogenesis of HIV-1-associated dementia (HAD), What remains unanswered, however, is the composition of and mechanisms for such MP-induced neurological dysfunctions. In attempts to address these issues culture fluids from HIV-1(ADA)-infected monocyte-derived macrophages (MDMs) (depleted or enriched with progeny virus) were placed onto the CA1 area of rat hippocampal brain slices (the site of mammalian learning and memory) and neuronal long-term potentiation (LTP) assayed. LTP was induced by high frequency stimulation (HFS). Lipopolysaccharide (LPS) served as a surrogate macrophage activator. Synaptic strength was assayed by the initial slope of evoked field excitatory postsynaptic potentials (EPSPs). Synaptic potentiation following HFS was observed in slices incubated with uninfected (control) MDM culture fluids. The magnitude of the LTP response was 150.2 +/- 21.10% compared to basal levels (n=6). Synaptic strength was enhanced in virus-infected (135.7 +/- 28.9%, n=8) and LPS-activated MDM (123.3 +/- 5.1%, n=7) but at lower levels than controls. The lowest levels of LTP were in brain slices incubated with virus-infected and LPS-activated MDM fluids at (109.5 +/- 9.9% n=12). Interestingly, bath application of progeny HIV-1 virions showed minimal LTP effects. Virus-infected, LPS-activated MDM fluids, with progeny virus, reduced synaptic strength but were not statistically different than replicate culture fluids depleted of virus. In contrast, IL-1 beta and quinolinic acid, significantly diminished synaptic strength. These results, taken together, suggest that soluble HIV-1-infected MDM secretory products, but not virus per se, significantly affect LTP. This electrophysiological system, which monitors neuronal function following cell exposure to HIV-1 infected materials could provide a novel testing ground for therapeutics designed to protect brain function in HAD.

HIV-1 gp120 enhances outward potassium current via CXCR4 and cAMP-dependent protein kinase A signaling in cultured rat microglia.

HIV-1gp120 Induces Neuronal Apoptosis Through Enhancement of 4-Aminopyridine-senstive Outward K+ Currents

Gp120 Binding with DC-SIGN Induces Reactivation of HIV-1 Provirus Via the NF-κB Signaling Pathway

HIV-1 envelope protein gp120 modulation of glutamate effects on cortical neuronal synapses: implications for HIV-1-associated neuropathogenesis

Human Immunodeficiency Virus Type 1 Gp120 Inhibits Long‐term Potentiation Via Chemokine Receptor CXCR4 in Rat Hippocampal Slices

Glutaminase Dysregulation in Hiv-1-Infected Human Microglia Mediates Neurotoxicity: Relevant to Hiv-1-Associated Neurocognitive Disorders

p62 promotes HIV-1 gp120 V3 loop-mediated microglial inflammation by promoting noncanonical activation of Nrf2

Effect of HIV-1 Gp120 on Electrophysiological Characteristics in Hippocampal Slices of Rats

HIV-1 Infected Immune Competent Mononuclear Phagocytes Influence the Pathways to Neuronal Demise.

NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology

Glutaminase-containing microvesicles from HIV-1-infected macrophages and immune-activated microglia induce neurotoxicity

Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: implications for human immunodeficiency virus type 1-associated dementia.

In vitro glutaminase regulation and mechanisms of glutamate generation in HIV-1-infected macrophage.

HIV-1 gp120 induces autophagy in cardiomyocytes via the NMDA receptor

HIV-infected Macrophages Mediate Neuronal Apoptosis Through Mitochondrial Glutaminase

Unraveling the Mechanisms of Neurotoxicity in HIV Type 1-Associated Dementia: Inhibition of Neuronal Synaptic Transmission by Macrophage Secretory Products

Effect of naringin on gp120-induced injury mediated by P2X7 receptors in rat primary cultured microglia.

Intracellular CXCR4 Signaling, Neuronal Apoptosis and Neuropathogenic Mechanisms of HIV-1-associated Dementia

Soluble Hiv-1 Infected Macrophage Secretory Products Mediate Blockade Of Long-Term Potentiation: A Mechanism For Cognitive Dysfunction In Hiv-1-Associated Dementia

Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages

NMDA receptor antagonists engender neuroprotection against gp120-induced cognitive dysfunction in rats through modulation of PKR activation, oxidative stress, ER stress and IRE1α signal pathway